nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—XDH—Doxorubicin—liver cancer	0.554	1	CbGbCtD
Allopurinol—Sepsis—Epirubicin—liver cancer	0.000916	0.00207	CcSEcCtD
Allopurinol—Lymphadenopathy—Epirubicin—liver cancer	0.000898	0.00203	CcSEcCtD
Allopurinol—Dyspepsia—Sorafenib—liver cancer	0.000897	0.00203	CcSEcCtD
Allopurinol—Coma—Doxorubicin—liver cancer	0.000893	0.00202	CcSEcCtD
Allopurinol—Rash maculo-papular—Doxorubicin—liver cancer	0.000888	0.002	CcSEcCtD
Allopurinol—Decreased appetite—Sorafenib—liver cancer	0.000886	0.002	CcSEcCtD
Allopurinol—Thrombophlebitis—Epirubicin—liver cancer	0.000885	0.002	CcSEcCtD
Allopurinol—Ecchymosis—Doxorubicin—liver cancer	0.000883	0.00199	CcSEcCtD
Allopurinol—Diabetes mellitus—Epirubicin—liver cancer	0.000881	0.00199	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Sorafenib—liver cancer	0.00088	0.00199	CcSEcCtD
Allopurinol—Hepatic function abnormal—Epirubicin—liver cancer	0.000877	0.00198	CcSEcCtD
Allopurinol—Constipation—Sorafenib—liver cancer	0.000871	0.00197	CcSEcCtD
Allopurinol—Pain—Sorafenib—liver cancer	0.000871	0.00197	CcSEcCtD
Allopurinol—Vascular purpura—Epirubicin—liver cancer	0.000857	0.00193	CcSEcCtD
Allopurinol—Eczema—Epirubicin—liver cancer	0.000853	0.00193	CcSEcCtD
Allopurinol—Hepatic failure—Epirubicin—liver cancer	0.000853	0.00193	CcSEcCtD
Allopurinol—Sepsis—Doxorubicin—liver cancer	0.000848	0.00191	CcSEcCtD
Allopurinol—Gastrointestinal pain—Sorafenib—liver cancer	0.000833	0.00188	CcSEcCtD
Allopurinol—Lymphadenopathy—Doxorubicin—liver cancer	0.000831	0.00188	CcSEcCtD
Allopurinol—Renal failure acute—Epirubicin—liver cancer	0.00083	0.00187	CcSEcCtD
Allopurinol—Thrombophlebitis—Doxorubicin—liver cancer	0.000819	0.00185	CcSEcCtD
Allopurinol—Diabetes mellitus—Doxorubicin—liver cancer	0.000815	0.00184	CcSEcCtD
Allopurinol—Dermatitis exfoliative—Epirubicin—liver cancer	0.000812	0.00183	CcSEcCtD
Allopurinol—Hepatic function abnormal—Doxorubicin—liver cancer	0.000811	0.00183	CcSEcCtD
Allopurinol—Urticaria—Sorafenib—liver cancer	0.00081	0.00183	CcSEcCtD
Allopurinol—Abdominal pain—Sorafenib—liver cancer	0.000806	0.00182	CcSEcCtD
Allopurinol—Body temperature increased—Sorafenib—liver cancer	0.000806	0.00182	CcSEcCtD
Allopurinol—Renal impairment—Epirubicin—liver cancer	0.000805	0.00182	CcSEcCtD
Allopurinol—Dermatitis bullous—Epirubicin—liver cancer	0.000802	0.00181	CcSEcCtD
Allopurinol—Purpura—Epirubicin—liver cancer	0.000795	0.00179	CcSEcCtD
Allopurinol—Vascular purpura—Doxorubicin—liver cancer	0.000793	0.00179	CcSEcCtD
Allopurinol—Eczema—Doxorubicin—liver cancer	0.000789	0.00178	CcSEcCtD
Allopurinol—Hepatic failure—Doxorubicin—liver cancer	0.000789	0.00178	CcSEcCtD
Allopurinol—Cardiac failure—Epirubicin—liver cancer	0.000785	0.00177	CcSEcCtD
Allopurinol—Cerebrovascular accident—Epirubicin—liver cancer	0.000782	0.00177	CcSEcCtD
Allopurinol—Hyponatraemia—Epirubicin—liver cancer	0.000769	0.00174	CcSEcCtD
Allopurinol—Renal failure acute—Doxorubicin—liver cancer	0.000768	0.00173	CcSEcCtD
Allopurinol—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000766	0.00173	CcSEcCtD
Allopurinol—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000751	0.0017	CcSEcCtD
Allopurinol—Hypersensitivity—Sorafenib—liver cancer	0.000751	0.0017	CcSEcCtD
Allopurinol—Renal impairment—Doxorubicin—liver cancer	0.000745	0.00168	CcSEcCtD
Allopurinol—Dermatitis bullous—Doxorubicin—liver cancer	0.000742	0.00167	CcSEcCtD
Allopurinol—Face oedema—Epirubicin—liver cancer	0.00074	0.00167	CcSEcCtD
Allopurinol—Purpura—Doxorubicin—liver cancer	0.000736	0.00166	CcSEcCtD
Allopurinol—Asthenia—Sorafenib—liver cancer	0.000731	0.00165	CcSEcCtD
Allopurinol—Cardiac failure—Doxorubicin—liver cancer	0.000727	0.00164	CcSEcCtD
Allopurinol—Cerebrovascular accident—Doxorubicin—liver cancer	0.000724	0.00163	CcSEcCtD
Allopurinol—Pruritus—Sorafenib—liver cancer	0.000721	0.00163	CcSEcCtD
Allopurinol—Ataxia—Epirubicin—liver cancer	0.000721	0.00163	CcSEcCtD
Allopurinol—Blood creatinine increased—Epirubicin—liver cancer	0.000718	0.00162	CcSEcCtD
Allopurinol—Hyponatraemia—Doxorubicin—liver cancer	0.000712	0.00161	CcSEcCtD
Allopurinol—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000709	0.0016	CcSEcCtD
Allopurinol—Abdominal pain upper—Epirubicin—liver cancer	0.0007	0.00158	CcSEcCtD
Allopurinol—Hypokalaemia—Epirubicin—liver cancer	0.000697	0.00157	CcSEcCtD
Allopurinol—Diarrhoea—Sorafenib—liver cancer	0.000697	0.00157	CcSEcCtD
Allopurinol—Breast disorder—Epirubicin—liver cancer	0.000692	0.00156	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00069	0.00156	CcSEcCtD
Allopurinol—Face oedema—Doxorubicin—liver cancer	0.000685	0.00155	CcSEcCtD
Allopurinol—Gastritis—Epirubicin—liver cancer	0.000678	0.00153	CcSEcCtD
Allopurinol—Dizziness—Sorafenib—liver cancer	0.000674	0.00152	CcSEcCtD
Allopurinol—Abdominal distension—Epirubicin—liver cancer	0.000667	0.00151	CcSEcCtD
Allopurinol—Ataxia—Doxorubicin—liver cancer	0.000667	0.00151	CcSEcCtD
Allopurinol—Blood creatinine increased—Doxorubicin—liver cancer	0.000664	0.0015	CcSEcCtD
Allopurinol—Asthma—Epirubicin—liver cancer	0.000662	0.0015	CcSEcCtD
Allopurinol—Eosinophilia—Epirubicin—liver cancer	0.000656	0.00148	CcSEcCtD
Allopurinol—Vomiting—Sorafenib—liver cancer	0.000648	0.00146	CcSEcCtD
Allopurinol—Abdominal pain upper—Doxorubicin—liver cancer	0.000648	0.00146	CcSEcCtD
Allopurinol—Hypokalaemia—Doxorubicin—liver cancer	0.000645	0.00146	CcSEcCtD
Allopurinol—Angina pectoris—Epirubicin—liver cancer	0.000645	0.00146	CcSEcCtD
Allopurinol—Rash—Sorafenib—liver cancer	0.000643	0.00145	CcSEcCtD
Allopurinol—Dermatitis—Sorafenib—liver cancer	0.000642	0.00145	CcSEcCtD
Allopurinol—Breast disorder—Doxorubicin—liver cancer	0.000641	0.00145	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000638	0.00144	CcSEcCtD
Allopurinol—Headache—Sorafenib—liver cancer	0.000638	0.00144	CcSEcCtD
Allopurinol—Pancytopenia—Epirubicin—liver cancer	0.000629	0.00142	CcSEcCtD
Allopurinol—Gastritis—Doxorubicin—liver cancer	0.000628	0.00142	CcSEcCtD
Allopurinol—Dysuria—Epirubicin—liver cancer	0.000619	0.0014	CcSEcCtD
Allopurinol—Neutropenia—Epirubicin—liver cancer	0.000619	0.0014	CcSEcCtD
Allopurinol—Abdominal distension—Doxorubicin—liver cancer	0.000617	0.00139	CcSEcCtD
Allopurinol—Asthma—Doxorubicin—liver cancer	0.000613	0.00138	CcSEcCtD
Allopurinol—Eosinophilia—Doxorubicin—liver cancer	0.000607	0.00137	CcSEcCtD
Allopurinol—Nausea—Sorafenib—liver cancer	0.000605	0.00137	CcSEcCtD
Allopurinol—Weight increased—Epirubicin—liver cancer	0.000603	0.00136	CcSEcCtD
Allopurinol—Hyperglycaemia—Epirubicin—liver cancer	0.000597	0.00135	CcSEcCtD
Allopurinol—Angina pectoris—Doxorubicin—liver cancer	0.000597	0.00135	CcSEcCtD
Allopurinol—Drowsiness—Epirubicin—liver cancer	0.000591	0.00133	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000585	0.00132	CcSEcCtD
Allopurinol—Pancytopenia—Doxorubicin—liver cancer	0.000582	0.00131	CcSEcCtD
Allopurinol—Neuropathy peripheral—Epirubicin—liver cancer	0.000579	0.00131	CcSEcCtD
Allopurinol—Stomatitis—Epirubicin—liver cancer	0.000576	0.0013	CcSEcCtD
Allopurinol—Jaundice—Epirubicin—liver cancer	0.000576	0.0013	CcSEcCtD
Allopurinol—Urinary tract infection—Epirubicin—liver cancer	0.000574	0.0013	CcSEcCtD
Allopurinol—Conjunctivitis—Epirubicin—liver cancer	0.000574	0.0013	CcSEcCtD
Allopurinol—Dysuria—Doxorubicin—liver cancer	0.000573	0.00129	CcSEcCtD
Allopurinol—Neutropenia—Doxorubicin—liver cancer	0.000573	0.00129	CcSEcCtD
Allopurinol—Sweating—Epirubicin—liver cancer	0.000566	0.00128	CcSEcCtD
Allopurinol—Haematuria—Epirubicin—liver cancer	0.000563	0.00127	CcSEcCtD
Allopurinol—Hepatobiliary disease—Epirubicin—liver cancer	0.000558	0.00126	CcSEcCtD
Allopurinol—Weight increased—Doxorubicin—liver cancer	0.000558	0.00126	CcSEcCtD
Allopurinol—Epistaxis—Epirubicin—liver cancer	0.000557	0.00126	CcSEcCtD
Allopurinol—Hyperglycaemia—Doxorubicin—liver cancer	0.000553	0.00125	CcSEcCtD
Allopurinol—Agranulocytosis—Epirubicin—liver cancer	0.000551	0.00124	CcSEcCtD
Allopurinol—Drowsiness—Doxorubicin—liver cancer	0.000546	0.00123	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000542	0.00122	CcSEcCtD
Allopurinol—Bradycardia—Epirubicin—liver cancer	0.00054	0.00122	CcSEcCtD
Allopurinol—Neuropathy peripheral—Doxorubicin—liver cancer	0.000536	0.00121	CcSEcCtD
Allopurinol—Haemoglobin—Epirubicin—liver cancer	0.000533	0.0012	CcSEcCtD
Allopurinol—Jaundice—Doxorubicin—liver cancer	0.000533	0.0012	CcSEcCtD
Allopurinol—Stomatitis—Doxorubicin—liver cancer	0.000533	0.0012	CcSEcCtD
Allopurinol—Rhinitis—Epirubicin—liver cancer	0.000531	0.0012	CcSEcCtD
Allopurinol—Conjunctivitis—Doxorubicin—liver cancer	0.000531	0.0012	CcSEcCtD
Allopurinol—Urinary tract infection—Doxorubicin—liver cancer	0.000531	0.0012	CcSEcCtD
Allopurinol—Haemorrhage—Epirubicin—liver cancer	0.00053	0.0012	CcSEcCtD
Allopurinol—Hepatitis—Epirubicin—liver cancer	0.00053	0.0012	CcSEcCtD
Allopurinol—Hypoaesthesia—Epirubicin—liver cancer	0.000527	0.00119	CcSEcCtD
Allopurinol—Pharyngitis—Epirubicin—liver cancer	0.000526	0.00119	CcSEcCtD
Allopurinol—Sweating—Doxorubicin—liver cancer	0.000524	0.00118	CcSEcCtD
Allopurinol—Urinary tract disorder—Epirubicin—liver cancer	0.000524	0.00118	CcSEcCtD
Allopurinol—Haematuria—Doxorubicin—liver cancer	0.000521	0.00118	CcSEcCtD
Allopurinol—Urethral disorder—Epirubicin—liver cancer	0.00052	0.00117	CcSEcCtD
Allopurinol—Hepatobiliary disease—Doxorubicin—liver cancer	0.000517	0.00117	CcSEcCtD
Allopurinol—Epistaxis—Doxorubicin—liver cancer	0.000515	0.00116	CcSEcCtD
Allopurinol—Visual impairment—Epirubicin—liver cancer	0.000511	0.00115	CcSEcCtD
Allopurinol—Agranulocytosis—Doxorubicin—liver cancer	0.00051	0.00115	CcSEcCtD
Allopurinol—Erythema multiforme—Epirubicin—liver cancer	0.000501	0.00113	CcSEcCtD
Allopurinol—Bradycardia—Doxorubicin—liver cancer	0.000499	0.00113	CcSEcCtD
Allopurinol—Eye disorder—Epirubicin—liver cancer	0.000495	0.00112	CcSEcCtD
Allopurinol—Tinnitus—Epirubicin—liver cancer	0.000494	0.00112	CcSEcCtD
Allopurinol—Haemoglobin—Doxorubicin—liver cancer	0.000493	0.00111	CcSEcCtD
Allopurinol—Flushing—Epirubicin—liver cancer	0.000492	0.00111	CcSEcCtD
Allopurinol—Cardiac disorder—Epirubicin—liver cancer	0.000492	0.00111	CcSEcCtD
Allopurinol—Rhinitis—Doxorubicin—liver cancer	0.000492	0.00111	CcSEcCtD
Allopurinol—Hepatitis—Doxorubicin—liver cancer	0.000491	0.00111	CcSEcCtD
Allopurinol—Haemorrhage—Doxorubicin—liver cancer	0.000491	0.00111	CcSEcCtD
Allopurinol—Hypoaesthesia—Doxorubicin—liver cancer	0.000488	0.0011	CcSEcCtD
Allopurinol—Pharyngitis—Doxorubicin—liver cancer	0.000487	0.0011	CcSEcCtD
Allopurinol—Urinary tract disorder—Doxorubicin—liver cancer	0.000484	0.00109	CcSEcCtD
Allopurinol—Urethral disorder—Doxorubicin—liver cancer	0.000481	0.00109	CcSEcCtD
Allopurinol—Immune system disorder—Epirubicin—liver cancer	0.000479	0.00108	CcSEcCtD
Allopurinol—Chills—Epirubicin—liver cancer	0.000476	0.00107	CcSEcCtD
Allopurinol—Visual impairment—Doxorubicin—liver cancer	0.000473	0.00107	CcSEcCtD
Allopurinol—Alopecia—Epirubicin—liver cancer	0.000468	0.00106	CcSEcCtD
Allopurinol—Mental disorder—Epirubicin—liver cancer	0.000464	0.00105	CcSEcCtD
Allopurinol—Erythema multiforme—Doxorubicin—liver cancer	0.000464	0.00105	CcSEcCtD
Allopurinol—Malnutrition—Epirubicin—liver cancer	0.000461	0.00104	CcSEcCtD
Allopurinol—Eye disorder—Doxorubicin—liver cancer	0.000458	0.00103	CcSEcCtD
Allopurinol—Tinnitus—Doxorubicin—liver cancer	0.000457	0.00103	CcSEcCtD
Allopurinol—Flushing—Doxorubicin—liver cancer	0.000455	0.00103	CcSEcCtD
Allopurinol—Cardiac disorder—Doxorubicin—liver cancer	0.000455	0.00103	CcSEcCtD
Allopurinol—Flatulence—Epirubicin—liver cancer	0.000455	0.00103	CcSEcCtD
Allopurinol—Dysgeusia—Epirubicin—liver cancer	0.000452	0.00102	CcSEcCtD
Allopurinol—Immune system disorder—Doxorubicin—liver cancer	0.000443	0.001	CcSEcCtD
Allopurinol—Chills—Doxorubicin—liver cancer	0.00044	0.000994	CcSEcCtD
Allopurinol—Alopecia—Doxorubicin—liver cancer	0.000433	0.000979	CcSEcCtD
Allopurinol—Mental disorder—Doxorubicin—liver cancer	0.00043	0.00097	CcSEcCtD
Allopurinol—Ill-defined disorder—Epirubicin—liver cancer	0.000428	0.000967	CcSEcCtD
Allopurinol—Malnutrition—Doxorubicin—liver cancer	0.000427	0.000964	CcSEcCtD
Allopurinol—Anaemia—Epirubicin—liver cancer	0.000427	0.000963	CcSEcCtD
Allopurinol—Agitation—Epirubicin—liver cancer	0.000424	0.000957	CcSEcCtD
Allopurinol—Flatulence—Doxorubicin—liver cancer	0.000421	0.00095	CcSEcCtD
Allopurinol—Dysgeusia—Doxorubicin—liver cancer	0.000418	0.000944	CcSEcCtD
Allopurinol—Malaise—Epirubicin—liver cancer	0.000416	0.00094	CcSEcCtD
Allopurinol—Vertigo—Epirubicin—liver cancer	0.000415	0.000936	CcSEcCtD
Allopurinol—Leukopenia—Epirubicin—liver cancer	0.000413	0.000933	CcSEcCtD
Allopurinol—Convulsion—Epirubicin—liver cancer	0.0004	0.000903	CcSEcCtD
Allopurinol—Hypertension—Epirubicin—liver cancer	0.000398	0.0009	CcSEcCtD
Allopurinol—Ill-defined disorder—Doxorubicin—liver cancer	0.000396	0.000894	CcSEcCtD
Allopurinol—Anaemia—Doxorubicin—liver cancer	0.000395	0.000891	CcSEcCtD
Allopurinol—Myalgia—Epirubicin—liver cancer	0.000393	0.000887	CcSEcCtD
Allopurinol—Arthralgia—Epirubicin—liver cancer	0.000393	0.000887	CcSEcCtD
Allopurinol—Agitation—Doxorubicin—liver cancer	0.000392	0.000886	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00039	0.000881	CcSEcCtD
Allopurinol—Discomfort—Epirubicin—liver cancer	0.000388	0.000876	CcSEcCtD
Allopurinol—Malaise—Doxorubicin—liver cancer	0.000385	0.000869	CcSEcCtD
Allopurinol—Vertigo—Doxorubicin—liver cancer	0.000384	0.000866	CcSEcCtD
Allopurinol—Leukopenia—Doxorubicin—liver cancer	0.000382	0.000863	CcSEcCtD
Allopurinol—Confusional state—Epirubicin—liver cancer	0.00038	0.000857	CcSEcCtD
Allopurinol—Anaphylactic shock—Epirubicin—liver cancer	0.000377	0.00085	CcSEcCtD
Allopurinol—Oedema—Epirubicin—liver cancer	0.000377	0.00085	CcSEcCtD
Allopurinol—Infection—Epirubicin—liver cancer	0.000374	0.000845	CcSEcCtD
Allopurinol—Convulsion—Doxorubicin—liver cancer	0.00037	0.000835	CcSEcCtD
Allopurinol—Nervous system disorder—Epirubicin—liver cancer	0.000369	0.000834	CcSEcCtD
Allopurinol—Thrombocytopenia—Epirubicin—liver cancer	0.000369	0.000833	CcSEcCtD
Allopurinol—Hypertension—Doxorubicin—liver cancer	0.000369	0.000832	CcSEcCtD
Allopurinol—Skin disorder—Epirubicin—liver cancer	0.000366	0.000826	CcSEcCtD
Allopurinol—Hyperhidrosis—Epirubicin—liver cancer	0.000364	0.000822	CcSEcCtD
Allopurinol—Arthralgia—Doxorubicin—liver cancer	0.000364	0.000821	CcSEcCtD
Allopurinol—Myalgia—Doxorubicin—liver cancer	0.000364	0.000821	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000361	0.000815	CcSEcCtD
Allopurinol—Discomfort—Doxorubicin—liver cancer	0.000359	0.000811	CcSEcCtD
Allopurinol—Anorexia—Epirubicin—liver cancer	0.000359	0.000811	CcSEcCtD
Allopurinol—Hypotension—Epirubicin—liver cancer	0.000352	0.000795	CcSEcCtD
Allopurinol—Confusional state—Doxorubicin—liver cancer	0.000351	0.000793	CcSEcCtD
Allopurinol—Oedema—Doxorubicin—liver cancer	0.000348	0.000787	CcSEcCtD
Allopurinol—Anaphylactic shock—Doxorubicin—liver cancer	0.000348	0.000787	CcSEcCtD
Allopurinol—Infection—Doxorubicin—liver cancer	0.000346	0.000782	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000343	0.000775	CcSEcCtD
Allopurinol—Nervous system disorder—Doxorubicin—liver cancer	0.000342	0.000772	CcSEcCtD
Allopurinol—Thrombocytopenia—Doxorubicin—liver cancer	0.000341	0.00077	CcSEcCtD
Allopurinol—Insomnia—Epirubicin—liver cancer	0.000341	0.000769	CcSEcCtD
Allopurinol—Skin disorder—Doxorubicin—liver cancer	0.000338	0.000764	CcSEcCtD
Allopurinol—Paraesthesia—Epirubicin—liver cancer	0.000338	0.000764	CcSEcCtD
Allopurinol—Hyperhidrosis—Doxorubicin—liver cancer	0.000337	0.000761	CcSEcCtD
Allopurinol—Somnolence—Epirubicin—liver cancer	0.000335	0.000756	CcSEcCtD
Allopurinol—Anorexia—Doxorubicin—liver cancer	0.000332	0.00075	CcSEcCtD
Allopurinol—Dyspepsia—Epirubicin—liver cancer	0.000332	0.000748	CcSEcCtD
Allopurinol—Decreased appetite—Epirubicin—liver cancer	0.000327	0.000739	CcSEcCtD
Allopurinol—Hypotension—Doxorubicin—liver cancer	0.000326	0.000735	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Epirubicin—liver cancer	0.000325	0.000734	CcSEcCtD
Allopurinol—Constipation—Epirubicin—liver cancer	0.000322	0.000727	CcSEcCtD
Allopurinol—Pain—Epirubicin—liver cancer	0.000322	0.000727	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000318	0.000717	CcSEcCtD
Allopurinol—Insomnia—Doxorubicin—liver cancer	0.000315	0.000712	CcSEcCtD
Allopurinol—Paraesthesia—Doxorubicin—liver cancer	0.000313	0.000706	CcSEcCtD
Allopurinol—Feeling abnormal—Epirubicin—liver cancer	0.00031	0.000701	CcSEcCtD
Allopurinol—Somnolence—Doxorubicin—liver cancer	0.00031	0.000699	CcSEcCtD
Allopurinol—Gastrointestinal pain—Epirubicin—liver cancer	0.000308	0.000695	CcSEcCtD
Allopurinol—Dyspepsia—Doxorubicin—liver cancer	0.000307	0.000693	CcSEcCtD
Allopurinol—Decreased appetite—Doxorubicin—liver cancer	0.000303	0.000684	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000301	0.000679	CcSEcCtD
Allopurinol—Urticaria—Epirubicin—liver cancer	0.000299	0.000676	CcSEcCtD
Allopurinol—Pain—Doxorubicin—liver cancer	0.000298	0.000673	CcSEcCtD
Allopurinol—Constipation—Doxorubicin—liver cancer	0.000298	0.000673	CcSEcCtD
Allopurinol—Abdominal pain—Epirubicin—liver cancer	0.000298	0.000672	CcSEcCtD
Allopurinol—Body temperature increased—Epirubicin—liver cancer	0.000298	0.000672	CcSEcCtD
Allopurinol—Feeling abnormal—Doxorubicin—liver cancer	0.000287	0.000648	CcSEcCtD
Allopurinol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000285	0.000643	CcSEcCtD
Allopurinol—Hypersensitivity—Epirubicin—liver cancer	0.000277	0.000626	CcSEcCtD
Allopurinol—Urticaria—Doxorubicin—liver cancer	0.000277	0.000625	CcSEcCtD
Allopurinol—Abdominal pain—Doxorubicin—liver cancer	0.000275	0.000622	CcSEcCtD
Allopurinol—Body temperature increased—Doxorubicin—liver cancer	0.000275	0.000622	CcSEcCtD
Allopurinol—Asthenia—Epirubicin—liver cancer	0.00027	0.00061	CcSEcCtD
Allopurinol—Pruritus—Epirubicin—liver cancer	0.000266	0.000602	CcSEcCtD
Allopurinol—Diarrhoea—Epirubicin—liver cancer	0.000258	0.000582	CcSEcCtD
Allopurinol—Hypersensitivity—Doxorubicin—liver cancer	0.000257	0.00058	CcSEcCtD
Allopurinol—Asthenia—Doxorubicin—liver cancer	0.00025	0.000564	CcSEcCtD
Allopurinol—Dizziness—Epirubicin—liver cancer	0.000249	0.000562	CcSEcCtD
Allopurinol—Pruritus—Doxorubicin—liver cancer	0.000247	0.000557	CcSEcCtD
Allopurinol—Vomiting—Epirubicin—liver cancer	0.000239	0.000541	CcSEcCtD
Allopurinol—Diarrhoea—Doxorubicin—liver cancer	0.000238	0.000538	CcSEcCtD
Allopurinol—Rash—Epirubicin—liver cancer	0.000237	0.000536	CcSEcCtD
Allopurinol—Dermatitis—Epirubicin—liver cancer	0.000237	0.000536	CcSEcCtD
Allopurinol—Headache—Epirubicin—liver cancer	0.000236	0.000533	CcSEcCtD
Allopurinol—Dizziness—Doxorubicin—liver cancer	0.00023	0.00052	CcSEcCtD
Allopurinol—XDH—Oxidative Stress—NFE2L2—liver cancer	0.000224	0.0621	CbGpPWpGaD
Allopurinol—Nausea—Epirubicin—liver cancer	0.000224	0.000505	CcSEcCtD
Allopurinol—Vomiting—Doxorubicin—liver cancer	0.000222	0.0005	CcSEcCtD
Allopurinol—Rash—Doxorubicin—liver cancer	0.00022	0.000496	CcSEcCtD
Allopurinol—Dermatitis—Doxorubicin—liver cancer	0.00022	0.000496	CcSEcCtD
Allopurinol—Headache—Doxorubicin—liver cancer	0.000218	0.000493	CcSEcCtD
Allopurinol—XDH—Oxidative Stress—GPX3—liver cancer	0.000214	0.0592	CbGpPWpGaD
Allopurinol—Nausea—Doxorubicin—liver cancer	0.000207	0.000467	CcSEcCtD
Allopurinol—XDH—Selenium Micronutrient Network—EPT1—liver cancer	0.000205	0.0567	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—HMOX1—liver cancer	0.000133	0.0369	CbGpPWpGaD
Allopurinol—AOX1—Tryptophan metabolism—CYP2E1—liver cancer	0.000125	0.0347	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—CYP1A1—liver cancer	0.000118	0.0326	CbGpPWpGaD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.000112	0.0311	CbGpPWpGaD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.000107	0.0296	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—MAPK14—liver cancer	9.96e-05	0.0275	CbGpPWpGaD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	9.44e-05	0.0261	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—GPX3—liver cancer	9.05e-05	0.025	CbGpPWpGaD
Allopurinol—AOX1—Tryptophan metabolism—CYP1A1—liver cancer	9.01e-05	0.0249	CbGpPWpGaD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	9.01e-05	0.0249	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—MTHFR—liver cancer	8.4e-05	0.0232	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—GGT1—liver cancer	6.37e-05	0.0176	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC11A2—liver cancer	5.1e-05	0.0141	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—MYO5B—liver cancer	5.07e-05	0.014	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC9C1—liver cancer	5.07e-05	0.014	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	5.04e-05	0.0139	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC40A1—liver cancer	4.87e-05	0.0135	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—MTHFR—liver cancer	4.65e-05	0.0128	CbGpPWpGaD
Allopurinol—AOX1—Disease—APCS—liver cancer	4.35e-05	0.012	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC11A2—liver cancer	4.29e-05	0.0119	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—MYO5B—liver cancer	4.26e-05	0.0118	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC9C1—liver cancer	4.26e-05	0.0118	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC40A1—liver cancer	4.09e-05	0.0113	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—F2—liver cancer	4.08e-05	0.0113	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—SERPINE1—liver cancer	3.39e-05	0.00939	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—ALB—liver cancer	3.39e-05	0.00937	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TP53—liver cancer	3.19e-05	0.00882	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.59e-05	0.00717	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.47e-05	0.00684	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ATP7B—liver cancer	2.37e-05	0.00656	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ANXA2—liver cancer	2.37e-05	0.00656	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—UGDH—liver cancer	2.35e-05	0.00649	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—NR1H4—liver cancer	2.24e-05	0.0062	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—EPT1—liver cancer	2.21e-05	0.0061	CbGpPWpGaD
Allopurinol—XDH—Metabolism—UGDH—liver cancer	2.18e-05	0.00603	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.18e-05	0.00603	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—TAT—liver cancer	2.09e-05	0.00578	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.08e-05	0.00575	CbGpPWpGaD
Allopurinol—XDH—Metabolism—EPT1—liver cancer	2.05e-05	0.00567	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—TNF—liver cancer	2e-05	0.00553	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	1.99e-05	0.00551	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	1.99e-05	0.00551	CbGpPWpGaD
Allopurinol—XDH—Metabolism—TAT—liver cancer	1.94e-05	0.00537	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	1.89e-05	0.00521	CbGpPWpGaD
Allopurinol—AOX1—Disease—LTF—liver cancer	1.7e-05	0.00469	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—IL6—liver cancer	1.61e-05	0.00447	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GLUL—liver cancer	1.42e-05	0.00393	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CPT1B—liver cancer	1.42e-05	0.00393	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—NR1H4—liver cancer	1.37e-05	0.00379	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTA3—liver cancer	1.35e-05	0.00373	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CPT1B—liver cancer	1.32e-05	0.00365	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GLUL—liver cancer	1.32e-05	0.00365	CbGpPWpGaD
Allopurinol—AOX1—Disease—ALDOB—liver cancer	1.31e-05	0.00363	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NR1H4—liver cancer	1.27e-05	0.00352	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTA3—liver cancer	1.25e-05	0.00346	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTA4—liver cancer	1.23e-05	0.00341	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTA2—liver cancer	1.2e-05	0.00332	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—ALB—liver cancer	1.17e-05	0.00325	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTA1—liver cancer	1.16e-05	0.0032	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—NAT2—liver cancer	1.15e-05	0.00317	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTA4—liver cancer	1.15e-05	0.00317	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—CYCS—liver cancer	1.14e-05	0.00316	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTA2—liver cancer	1.12e-05	0.00309	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ALDOB—liver cancer	1.1e-05	0.00304	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTA1—liver cancer	1.08e-05	0.00298	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NAT2—liver cancer	1.06e-05	0.00295	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CRABP1—liver cancer	1.05e-05	0.0029	CbGpPWpGaD
Allopurinol—AOX1—Disease—ADAM17—liver cancer	1.04e-05	0.00287	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ALDOB—liver cancer	1.02e-05	0.00282	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—HMOX1—liver cancer	9.94e-06	0.00275	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	9.87e-06	0.00273	CbGpPWpGaD
Allopurinol—AOX1—Disease—PSMD10—liver cancer	9.75e-06	0.0027	CbGpPWpGaD
Allopurinol—AOX1—Disease—PSMA4—liver cancer	9.75e-06	0.0027	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CRABP1—liver cancer	9.74e-06	0.00269	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	9.61e-06	0.00266	CbGpPWpGaD
Allopurinol—AOX1—Disease—GOT2—liver cancer	9.48e-06	0.00262	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—HPGDS—liver cancer	9.16e-06	0.00253	CbGpPWpGaD
Allopurinol—XDH—Metabolism—HPGDS—liver cancer	8.51e-06	0.00235	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	8.35e-06	0.00231	CbGpPWpGaD
Allopurinol—AOX1—Disease—GOT1—liver cancer	8.18e-06	0.00226	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PSMA4—liver cancer	8.16e-06	0.00226	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PSMD10—liver cancer	8.16e-06	0.00226	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—PPARA—liver cancer	8.03e-06	0.00222	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GOT2—liver cancer	7.94e-06	0.0022	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PSMA4—liver cancer	7.59e-06	0.0021	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PSMD10—liver cancer	7.59e-06	0.0021	CbGpPWpGaD
Allopurinol—AOX1—Disease—PRKCE—liver cancer	7.55e-06	0.00209	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CYP2E1—liver cancer	7.47e-06	0.00206	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GOT2—liver cancer	7.38e-06	0.00204	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CYCS—liver cancer	6.98e-06	0.00193	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYP2E1—liver cancer	6.94e-06	0.00192	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GOT1—liver cancer	6.85e-06	0.0019	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GGT1—liver cancer	6.85e-06	0.0019	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	6.75e-06	0.00187	CbGpPWpGaD
Allopurinol—AOX1—Disease—H2AFX—liver cancer	6.58e-06	0.00182	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYCS—liver cancer	6.49e-06	0.0018	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GOT1—liver cancer	6.37e-06	0.00176	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GGT1—liver cancer	6.37e-06	0.00176	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTP1—liver cancer	6.16e-06	0.0017	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—HMOX1—liver cancer	6.07e-06	0.00168	CbGpPWpGaD
Allopurinol—AOX1—Disease—MTHFR—liver cancer	5.97e-06	0.00165	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ALB—liver cancer	5.97e-06	0.00165	CbGpPWpGaD
Allopurinol—AOX1—Disease—TERT—liver cancer	5.95e-06	0.00165	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTP1—liver cancer	5.72e-06	0.00158	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTM1—liver cancer	5.66e-06	0.00156	CbGpPWpGaD
Allopurinol—XDH—Metabolism—HMOX1—liver cancer	5.64e-06	0.00156	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—RAF1—liver cancer	5.4e-06	0.00149	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CYP1A1—liver cancer	5.36e-06	0.00148	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTM1—liver cancer	5.26e-06	0.00145	CbGpPWpGaD
Allopurinol—AOX1—Disease—APC—liver cancer	5.02e-06	0.00139	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	5.02e-06	0.00139	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—MTHFR—liver cancer	5e-06	0.00138	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CYP1A1—liver cancer	4.99e-06	0.00138	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PPARA—liver cancer	4.91e-06	0.00136	CbGpPWpGaD
Allopurinol—AOX1—Disease—BRAF—liver cancer	4.71e-06	0.0013	CbGpPWpGaD
Allopurinol—XDH—Metabolism—MTHFR—liver cancer	4.65e-06	0.00129	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PPARA—liver cancer	4.56e-06	0.00126	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	4.54e-06	0.00125	CbGpPWpGaD
Allopurinol—AOX1—Disease—PIK3CD—liver cancer	4.41e-06	0.00122	CbGpPWpGaD
Allopurinol—AOX1—Disease—SERPINE1—liver cancer	4.36e-06	0.00121	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PIK3CG—liver cancer	4.2e-06	0.00116	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PPARG—liver cancer	4.05e-06	0.00112	CbGpPWpGaD
Allopurinol—AOX1—Disease—RAF1—liver cancer	3.94e-06	0.00109	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PIK3CG—liver cancer	3.91e-06	0.00108	CbGpPWpGaD
Allopurinol—AOX1—Disease—PIK3CB—liver cancer	3.84e-06	0.00106	CbGpPWpGaD
Allopurinol—AOX1—Disease—MTOR—liver cancer	3.84e-06	0.00106	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PPARG—liver cancer	3.77e-06	0.00104	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PIK3CD—liver cancer	3.69e-06	0.00102	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ALB—liver cancer	3.65e-06	0.00101	CbGpPWpGaD
Allopurinol—AOX1—Disease—CDKN1B—liver cancer	3.61e-06	0.000998	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PIK3CD—liver cancer	3.43e-06	0.000949	CbGpPWpGaD
Allopurinol—AOX1—Disease—CTNNB1—liver cancer	3.41e-06	0.000942	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ALB—liver cancer	3.39e-06	0.000937	CbGpPWpGaD
Allopurinol—AOX1—Disease—CDKN1A—liver cancer	3.33e-06	0.000921	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PIK3CB—liver cancer	3.22e-06	0.00089	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PIK3CB—liver cancer	2.99e-06	0.000828	CbGpPWpGaD
Allopurinol—AOX1—Disease—STAT3—liver cancer	2.97e-06	0.000821	CbGpPWpGaD
Allopurinol—AOX1—Disease—MYC—liver cancer	2.76e-06	0.000763	CbGpPWpGaD
Allopurinol—AOX1—Disease—TGFB1—liver cancer	2.75e-06	0.000761	CbGpPWpGaD
Allopurinol—AOX1—Disease—KRAS—liver cancer	2.55e-06	0.000705	CbGpPWpGaD
Allopurinol—AOX1—Disease—PIK3CA—liver cancer	2.34e-06	0.000648	CbGpPWpGaD
Allopurinol—AOX1—Disease—HRAS—liver cancer	2.17e-06	0.0006	CbGpPWpGaD
Allopurinol—AOX1—Disease—IL6—liver cancer	2.07e-06	0.000574	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PIK3CA—liver cancer	1.96e-06	0.000543	CbGpPWpGaD
Allopurinol—AOX1—Disease—AKT1—liver cancer	1.91e-06	0.000529	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PIK3CA—liver cancer	1.82e-06	0.000505	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—AKT1—liver cancer	1.6e-06	0.000443	CbGpPWpGaD
Allopurinol—XDH—Metabolism—AKT1—liver cancer	1.49e-06	0.000412	CbGpPWpGaD
